Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005580
Status:
COMPLETED
Last Update Posted:
2010-02-24
First Post:
2000-05-02
Brief Title:
Bryostatin Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkins Lymphoma
Sponsor:
Virginia Commonwealth University
Organization:
Virginia Commonwealth University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| Waldenstrom macroglobulinemia | View |
| stage I chronic lymphocytic leukemia | View |
| stage II chronic lymphocytic leukemia | View |
| stage III chronic lymphocytic leukemia | View |
| stage IV chronic lymphocytic leukemia | View |
| refractory chronic lymphocytic leukemia | View |
| T-cell large granular lymphocyte leukemia | View |
| B-cell chronic lymphocytic leukemia | View |
| refractory hairy cell leukemia | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult T-cell leukemialymphoma | View |
| prolymphocytic leukemia | View |
| recurrent mantle cell lymphoma | View |
| recurrent mycosis fungoidesSezary syndrome | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |
| splenic marginal zone lymphoma | View |